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Abstract
Following the submission of application EFSA-GMO-RX-012 under Regulation (EC) No 1829/2003 from
Bayer CropScience N.V., the Panel on Genetically Modiﬁed Organisms of the European Food Safety
Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted in the
context of the renewal of authorisation application for the herbicide-tolerant genetically modiﬁed oilseed
rape T45, for food and feed uses, excluding cultivation within the European Union. The data received in
the context of this renewal application contained post-market environmental monitoring reports, a
systematic search and evaluation of literature, updated bioinformatic analyses, and additional documents
or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible
new hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period
and not previously assessed in the context of the original application. Under the assumption that the DNA
sequence of the event in oilseed rape T45 considered for renewal is identical to the sequence of the
originally assessed event, the GMO Panel concludes that there is no evidence in the renewal application
EFSA-GMO-RX-012 for new hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the
conclusions of the original risk assessment on oilseed rape T45.
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Summary
Following the submission of application EFSA-GMO-RX-012 under Regulation (EC) No 1829/2003
from Bayer CropScience N.V., the Panel on Genetically Modiﬁed Organisms of the European Food
Safety Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted
in the context of the renewal of authorisation application for the herbicide-tolerant genetically modiﬁed
oilseed rape T45. The scope of renewal application EFSA-GMO-RX-012 is for placing on the market of
products containing or produced from oilseed rape T45, resulting from the commercialisation of this
oilseed rape in third countries until 2005, excluding cultivation in the European Union.1
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-012,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications. The data received in the context of the renewal application EFSA-
GMO-RX-012 contained: post-market environmental monitoring reports, an evaluation of the literature
retrieved by two systematic searches, updated bioinformatic analyses, and additional studies
performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new
hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period
and not previously assessed in the context of the original application.
Under the assumption that the DNA sequence of the event in oilseed rape T45 considered for
renewal is identical to the sequence of the originally assessed event, the GMO Panel concludes that
there is no evidence in renewal application EFSA-GMO-RX-012 for new hazards, modiﬁed exposure or
scientiﬁc uncertainties that would change the conclusions of the original risk assessment on oilseed
rape T45 (EFSA, 2008).
1 According to the information provided by the applicant, the de-registration of the oilseed rape T45 derived varieties was
completed in 2004 with the exception of a single line that was still sold in limited quantities until 2005. Oilseed rape T45 grown
historically in Canada and USA on a very limited surface may only enter the EU by import at low level in commodity rapeseed.
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1. Introduction
1.1. Background
On 1 March 2018, the European Food Safety Authority (EFSA) received from the European
Commission (DG SANTE) application EFSA-GMO-RX-012 by Bayer CropScience N.V. for the renewal of
authorisation of genetically modiﬁed (GM) oilseed rape T45 (Unique Identiﬁer ACS-GMØØ8-2) for the
placing on the market of products containing or produced from this GM oilseed rape for submitted within
the framework of Regulation (EC) No 1829/20032. Before sending the application to EFSA, the European
Commission conﬁrmed that the data submitted in the context of this renewal application were in line with
the legal requirements laid down in Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving application EFSA-GMO-RX-012, and in accordance with Articles 5(2)(b) and 17(2)(b)
of Regulation (EC) No 1829/2003, EFSA informed Member States and made the summary of the
application available to the public on the EFSA website.3
On 5 June 2018, EFSA declared the application valid in accordance with Articles 6(1) and 18(1) of
Regulation (EC) No 1829/2003. EFSA made the valid application available to Member States and the
European Commission, and consulted nominated risk assessment bodies of Member States, including
national Competent Authorities within the meaning of Directive 2001/18/EC following the requirements
of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member
States had three months after the opening of the Member State commenting period (until 10
September 2018) to make their opinion known.
Following the submission of applications EFSA-GMO-UK-2005-25 and EFSA-GMO-RX-T45, for which
one EFSA scientiﬁc opinion was published (EFSA, 2008), the placing on the market of oilseed rape T45
for products containing or produced from this GM oilseed rape resulting from the commercialisation of
this oilseed rape in third countries until 2005, excluding cultivation in the European Union (EU), was
authorised by Commission Decision 2009/184/EC4. A copy of this authorisation was provided by the
applicant.5
EFSA requested additional information on 19 June 2018, 10 October 2018, 22 October 2018 and
3 December 2018. The applicant submitted their replies on 17 August 2018, 6 November 2018,
6 December 2018 and 10 January 2019, respectively.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of six months from the acknowledgement of the valid application.
As additional information was requested by the Panel on Genetically Modiﬁed Organisms of the
European Food Safety Authority (GMO Panel), the time limit of 6 months was extended accordingly, in
line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
context of the renewal of authorisation application for the placing on the market of products
containing or produced from GM oilseed rape T45, in accordance with Articles 11 and 23 of Regulation
(EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food and feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environment
2 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
3 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2018-00229
4 COMMISSION DECISION of 10 March 2009 authorising the placing on the market of products containing or produced from
genetically modiﬁed oilseed rape T45 (ACS-GMØØ8-2) resulting from the commercialisation of this oilseed rape in third
countries until 2005, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council. Ofﬁcial Journal
of the European Union L 68/28, 13.3.2009.
5 Dossier: Oilseed rape T45 renewal – Annex 1.
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and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to the
Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and methods of
detection (including sampling and the identiﬁcation of the speciﬁc transformation event in the food and
feed and/or food and feed produced from it), which are matters related to risk management.
2. Data and methodologies
2.1. Data
The data for application EFSA-GMO-RX-012 provided by the applicant at the time of submission, or
in reply to requests for additional information are speciﬁed below.
In the context of this renewal application, no new sequence study was submitted among the
additional documents or studies performed by or on behalf of the applicant.6 In accordance with the
GMO Panel guidelines for renewal of applications of GM food and feed authorised under Regulation
(EC) No 1829/2003 (EFSA GMO Panel, 2015), the GMO Panel evaluated the data provided in the
context of this oilseed rape T45 renewal application under the assumption that the T45 event
sequence is identical to the sequence of the originally assessed event (EFSA, 2008).
2.1.1. Post-market monitoring reports7
Based on the outcome of the initial food and feed risk assessment, a post-market monitoring plan
for monitoring of GM food and feed was not required by the authorisation decision. The
implementation of a post-market environmental monitoring (PMEM) plan, consisting of a general
surveillance plan to check for any adverse effects on the environment arising from oilseed rape T45,
was a condition for the authorisation. As no potential adverse environmental effects were identiﬁed in
the environmental risk assessment of oilseed rape T45 (EFSA, 2008), case-speciﬁc monitoring was not
considered necessary by the GMO Panel.
The applicant provided ten annual PMEM reports covering a reporting period from March 2009 to
June 2018. The annual PMEM plans submitted by the applicant included (1) commodity crop (GM and
non-GM) imports into the EU by country of origin and destination; (2) the description of a centralised
system established by EuropaBio for the collection of information recorded by various operators
[federations involved in oilseed rape seeds import and processing] on any observed adverse effect(s)
on human health and the environment arising from handling of oilseed rape possibly containing oilseed
rape T45; (3) the reports of the surveillance activities conducted by such operators; and (4) the review
of relevant scientiﬁc peer-reviewed studies retrieved from literature searches.
2.1.2. Systematic search and evaluation of literature8
In addition to the ten separate literature searches provided as part of the annual PMEM reports, the
applicant performed two systematic literature searches for oilseed rape T45 and the newly expressed
phosphinothricin N-acetyltransferase (PAT) protein covering the period from 1 March 2009 till
30 September 2018, in accordance with the recommendations on literature searching outlined in EFSA
(2010, 2017a).
Searches in electronic bibliographic databases and in websites of relevant organisations were
performed to identify relevant publications. Altogether, 667 publications were retrieved. After applying
the eligibility/inclusion criteria deﬁned a priori by the applicant, ﬁve publications were identiﬁed as
relevant for food and feed safety assessment, molecular characterisation and environmental safety
assessment. The list of relevant publications is provided in Appendix A.
2.1.3. Updated bioinformatic data9
At the time of submission of the renewal dossier, the applicant provided a complete bioinformatic
dataset for the oilseed rape T45 event including an analysis of the insert and ﬂanking sequences, an
6 ossier: Oilseed rape T45 renewal – Section 2.3; additional information: 6/11/2018.
7 Dossier: Oilseed rape T45 renewal – Section 2.2; Annex 2; additional information: 10/1/2019.
8 Dossier Oilseed rape T45 renewal – Section 2.3.1; additional information: 17/8/2018 and 6/12/2018.
9 Dossier: Oilseed rape T45 renewal – Section 2.3.2.
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analysis of the potential similarity to allergens and toxins of the newly expressed protein and of all possible
ORFs within the insert and spanning the junction sites, and an analysis of possible horizontal gene transfer
(EFSA, 2017b). The outcome of the updated bioinformatic analyses is presented in Section 3.3.
2.1.4. Additional documents or studies provided by the applicant10
The applicant provided an overview on the worldwide approvals of oilseed rape T45 and the full
study reports of all studies performed by or on behalf of the applicant over the course of the
authorisation period and not previously submitted to the EU (Appendix B).
The relevance of these studies for molecular characterisation, human and animal safety and the
environment was assessed by the applicant.
2.1.5. Overall assessment as provided by the applicant11
The applicant provided an overall assessment concluding that information provided in the
application for renewal of authorisation of oilseed rape T45 for food and feed uses in the EU does not
change the outcome of the original risk assessment (EFSA, 2008).
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation12
The applicant indicated in the dossier that the environmental monitoring plan is appropriate and
does not need any changes.
2.2. Methodologies
The GMO Panel assessed the application for renewal of the authorisation of oilseed rape T45 for
food and feed uses in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003. The GMO
Panel took into account the requirements described in its guideline for the risk assessment of renewal
applications of GM food and feed authorised under Regulation (EC) No 1829/2003 (EFSA GMO Panel,
2015).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion13 and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Evaluation of the post-market monitoring reports
During the general surveillance activities covering the authorisation period of oilseed rape T45, no
adverse effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
The GMO Panel assessed the applicant’s literature searches on oilseed rape T45. Although the overall
quality of the performed literature searches is acceptable, the GMO Panel considers that future searches
could be improved. The GMO Panel therefore recommends the applicant for future searches to:
• ensure that enough search term variation is used (covering possible synonyms, related terms,
acronyms, spelling variants, old and new terminology, brand and generic names, lay and
scientiﬁc terminology, common typos, translation issues);
• include intended trait-speciﬁc search terms;
• ensure that enough truncation is used and use truncation consistently;
• include controlled vocabulary (subject indexing) in the searches when available, and, where
subject headings are available, use both free-text terms and controlled vocabulary in the
searches.
10 Dossier: Oilseed rape T45 renewal – Section 2.3.3.
11 Dossier: Oilseed rape T45 renewal – Section 2.3.4.
12 Dossier: Oilseed rape T45 renewal – Section 2.4.
13 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2019-00031
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The GMO Panel acknowledges that no publications raising a safety concern for human and animal
health and the environment which would change the original risk assessment conclusions on oilseed
rape T45 (EFSA, 2008) have been identiﬁed by the applicant.
3.3. Evaluation of the updated bioinformatic data
The results of the updated bioinformatic analysis of oilseed rape T45 conﬁrms that no known
endogenous genes were disrupted by the insert. Analyses of the amino acid sequence of the newly
expressed PAT protein reveal no signiﬁcant similarities to toxins or allergens. In addition, bioinformatic
analyses of the newly created ORFs within the insert or spanning the junctions with genomic DNA
reveal no signiﬁcant similarities to toxins and allergens.
The updated bioinformatic analysis for oilseed rape event T45 does not reveal any DNA sequence
that could provide sufﬁcient length and identity which could facilitate horizontal gene transfer by
double homologous recombination (HR), conﬁrming the previous conclusions (EFSA, 2008). Given the
results of this analysis and the potential of the recombinant DNA in oilseed rape T45 to confer selective
advantages or increased ﬁtness to microorganisms, the GMO Panel identiﬁed no safety concern linked
to an unlikely but theoretically possible HGT.
3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel evaluated the full study reports of the additional studies provided (Appendix B).
This new information does not raise any concern for human and animal health and the environment,
which would change the original risk assessment conclusions on oilseed rape T45.
3.5. Evaluation of the overall assessment as provided by the applicant
The GMO Panel evaluated the overall assessment provided by the applicant and conﬁrms that there
is no evidence in renewal application EFSA-GMO-RX-012 indicating new hazards, relevant changes in
exposure or scientiﬁc uncertainties that would change previous conclusions on oilseed rape T45.
3.6. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The PMEM plan covers general surveillance of imported GM plant material, including oilseed rape
T45. This general surveillance is coordinated by EuropaBio and implemented by selected operators
(federations involved in oilseed rape seeds import and processing). In addition, the applicant reviews
relevant scientiﬁc publications retrieved from literature searches on an annual basis. The GMO Panel is
of the opinion that the scope of the plan provided by the applicant is consistent with the scope of
oilseed rape T45, but reminds that monitoring is related to risk management, and thus the ﬁnal
adoption and implementation of the PMEM plan falls outside the mandate of EFSA.
4. Conclusions
Under the assumption that the DNA sequence of the event in oilseed rape T45 considered for
renewal is identical to the sequence of the originally assessed event, the GMO Panel concludes that
there is no evidence in the renewal application EFSA-GMO-RX-012 for new hazards, modiﬁed exposure
or scientiﬁc uncertainties that would change the conclusions of the original risk assessment on oilseed
rape T45 (EFSA, 2008).
Documentation provided to EFSA
1) Letter from the European Commission to EFSA received on 1 March 2018 for the continued
marketing of genetically modiﬁed oilseed rape T45 in accordance with articles 11 and 23 of
Regulation (EC) No 1829/2003 by Bayer (EFSA-GMO-RX-012).
2) Acknowledgement letter, dated 9 March 2018, from EFSA to the European Commission.
3) Letter from EFSA to applicant dated 17 April 2018 requesting additional information under
completeness check.
4) Letter from applicant to EFSA received on 14 May 2018 providing additional information
under completeness check.
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5) Letter from EFSA to applicant dated 5 June 2018 delivering the ‘Statement of Validity’ for
application EFSA-GMO-RX-012.
6) Letter from EFSA to applicant dated 19 June 2018 requesting additional information and
stopping the clock.
7) Letter from applicant to EFSA received on 17 August 2018 providing additional information.
8) Letter from EFSA to applicant dated 20 August 2018 re-starting the clock from 17 August
2018.
9) Letter from EFSA to applicant dated 10 October 2018 requesting additional information and
stopping the clock.
10) Letter from EFSA to applicant dated 22 October 2018 requesting additional information and
remaining the clock stop.
11) Letter from applicant to EFSA received on 6 November 2018 providing additional information.
12) Letter from EFSA to applicant dated 3 December 2018 requesting additional information and
remaining the clock stop.
13) Letter from applicant to EFSA received on 6 December 2018 providing additional information.
14) Letter from applicant to EFSA received on 10 January 2019 providing additional information.
15) Letter from EFSA to applicant dated 11 January 2019 re-starting the clock from
10 January 2019.
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Appendix B – List of additional studies performed by or on behalf of the
applicant over the course of the authorisation period and not previously
submitted to the EU with regard to the evaluation of the safety of the food
and feed for humans, animal or the environment from oilseed rape T45
Study identiﬁcation Title
M-475440-01-1 PAT protein-acute toxicity by oral gavage in mice
M-500889-01-1 The effect of temperature on microbially-produced PAT/pat as assessed
by ELISA
M-517325-01-1 Flanking sequence and inserted sequence for canola T45
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